Theriva Biologics, Inc.TOVXNYSE
Loading
Debt Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change
Year-over-year debt growth rate
Latest
-4.46%
↓ 157% vs avg
Percentile
P33
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
7.83%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -4.46% |
| Q2 2025 | 1.26% |
| Q1 2025 | 82.43% |
| Q4 2024 | -10.01% |
| Q3 2024 | -4.97% |
| Q2 2024 | -9.32% |
| Q1 2024 | -6.31% |
| Q4 2023 | -3.06% |
| Q3 2023 | -5.69% |
| Q2 2023 | -4.42% |
| Q1 2023 | 46.64% |
| Q4 2022 | 1.57% |
| Q3 2022 | -2.53% |
| Q2 2022 | -4.28% |
| Q1 2022 | 16.18% |
| Q4 2021 | -3.11% |
| Q3 2021 | -2.84% |
| Q2 2021 | 300.49% |
| Q1 2021 | -14.38% |
| Q4 2020 | -12.24% |
| Q3 2020 | -10.47% |
| Q2 2020 | -9.20% |
| Q1 2020 | -8.17% |
| Q4 2019 | -7.44% |
| Q3 2019 | -6.47% |
| Q2 2019 | -5.98% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |